Latest Property Portfolio News

Mesoblast has received a Biologics License Application filing number from the FDA for rexlemestrocel-L, targeting life-threatening bleeding in end-stage heart failure patients with LVADs, advancing its regulatory journey with orphan drug and RMAT designations.

ClearVue Technologies is inviting eligible shareholders to participate in a $1 million Share Purchase Plan at a discount, following a $5 million institutional placement. The capital raised will support ERP rollout, R&D, and working capital.

Booster Investment Scheme 2's Private Land and Property Fund swung back to profit with NZD 1.3 million after tax for the year ended March 2026, despite net asset value slipping due to unit redemptions. The Fund’s investment portfolio remains concentrated in unlisted New Zealand agricultural and property assets, while its Manager faces unrelated FMA proceedings.

Mesoblast has drawn US$50 million from a new five-year facility that reduces its interest burden and retires expensive short-term debt, strengthening its financial position ahead of commercial expansion.

Goodman NZ (NZX:GNZ) posted a 126% jump in statutory profit to $248 million for FY26, underpinned by strong property revaluations and leasing gains. The group completed its corporatisation and stapling, launched a property funds management platform, and progressed a development pipeline exceeding $1 billion.

Charter Hall (ASX: CHC) has announced a 6% increase in its full-year distribution to 50.67 cents per security for FY26, reflecting steady income growth and a fully franked dividend component.

Cynata Therapeutics (ASX: CYP) has had its trading suspension lifted immediately following the publication of results from its Phase 3 Osteoarthritis and Phase 2 Graft versus Host Disease clinical trials.

Region Group's investment property portfolio valuation rose by $94.8 million to $4.6 billion as at June 2026, supported by acquisitions and capital expenditure. The group also declared a final FY26 distribution of 7.2 cents per security, suspending its distribution reinvestment plan.

The GPT Wholesale Shopping Centre Fund is set to deepen its retail property exposure with a $1.2 billion acquisition of interests in two major super-regional shopping centres, Sunshine Plaza and Macarthur Square. This move leverages recent capital raises and underlines GPT's strategy to scale through partnerships.

Ryman Healthcare nearly doubles operating profitability and generates positive free cash flow for the first time in over a decade, while shifting strategy toward sustainable growth and targeting dividend returns by FY28.

Opthea Limited resumes ASX trading as it pivots to develop OPT-302 for lymphangioleiomyomatosis, outlining a disciplined 18-month staged clinical program backed by A$31.2 million in cash.

Stride Property Group posted a 44% jump in FY26 profit after tax to $31.3 million, driven by strategic portfolio moves, management fee growth, and sustainability progress. The group maintained an 8.0cps dividend amid a $1.4 billion diversified property portfolio and a strong balance sheet.